HPGC Renmintongtai Pharmaceutical Corporation announced earnings results for the half year ended June 30, 2021. For the half year, the company announced sales was CNY 4,664.082 million compared to CNY 3,502.675 million a year ago. Operating income was CNY 179.193 million compared to CNY 110.460 million a year ago. Net income was CNY 136.404 million compared to CNY 80.655 million a year ago. Basic earnings per share from continuing operations was CNY 0.2352 compared to CNY 0.1391 a year ago.